Archive | BIOTRONIK

BIOTRONIK - Archive

2021
15
July
2021
| 07:18 Europe/Amsterdam
As economically prosperous as the EU is, its population is gradually aging. By 2040, 155 million people in the EU will be over the age of 65. In many ways, this is good news, as well-developed health systems offer Europeans some of the best medical c...
Read more
18
June
2021
| 18:22 Europe/Amsterdam
BIOTRONIK ha anunciado hoy un evento online en el que se debatirán los resultados de un reciente estudio1 centrado en la comparación de los electrodos de estimulación guiados por estilete con los electrodos sin lumen, que son actualmente el estándar ...
Read more
17
June
2021
| 09:30 Europe/Amsterdam
BIOTRONIK has today announced an online event which will discuss insights from a recent study1 that focused on comparing stylet-driven pacing leads with lumen-less leads, that are currently industry standard for left-bundle branch area pacing (LBBAP)...
Read more
16
June
2021
| 12:01 Europe/Amsterdam
MRI scans are an important tool for diagnosing many different illnesses and conditions. With each passing year, more and more patients with implanted pacemakers, defibrillators, cardiac monitors and cardiac resynchronization implants gain greater acc...
Read more
03
June
2021
| 09:15 Europe/Amsterdam
For cardiology patients fitted with an implantable cardioverter-defibrillator (ICD) or pacemaker, remote monitoring is a blessing: knowing that the implant is being monitored for technical and medical abnormalities during office hours provides enormo...
Read more
20
May
2021
| 13:33 Europe/Amsterdam
More than 200 years after James Lind experimented with citrus fruits as a way to fight scurvy in sailors – in what is thought to be the world’s first clinical trial – we mark May 20 as Clinical Trials Day. On this day, we spotlight and celebrate adva...
Read more
19
May
2021
| 17:21 Europe/Amsterdam
On May 20, 1747, James Lind conducted what’s thought to be the world’s first clinical trial on board Britain’s HMS Salisbury. More than 200 years after Lind experimented with citrus fruits as a way to fight scurvy in sailors, we mark May 20 as Clinic...
Read more
18
May
2021
| 09:00 Europe/Amsterdam
New, long-term follow-up data from the BIOSOLVE-IV real-world registry strengthens the clinical evidence for BIOTRONIK’s Magmaris® Resorbable Magnesium Scaffold (RMS) as a therapy option for patients with coronary artery disease. Prof. Jan Torzewski,...
Read more
12
May
2021
| 10:22 Europe/Amsterdam
BIOTRONIK has today announced a virtual live event series, for implanting cardiologists, kicking off next week. The series will explore the clinical applications of the newest suite of Conduction System Pacing (CSP) tools, released by the company.The...
Read more
10
May
2021
| 15:14 Europe/Amsterdam
Well into its third decade of clinical use, cardiac resynchronization therapy still isn’t able to help all patients with a relevant indication. One 2017 study found that up to 30 percent of patients are “non-responders.” Technology, like BIOTRONIK’s ...
Read more
21
April
2021
| 09:08 Europe/Amsterdam
BIOTRONIK has today unveiled the newest suite of tools for the more specialized implanting procedures in the His-bundle cardiac conduction system. The company will present the tools to cardiologists this week as part of European Heart Rhythm Associat...
Read more
20
April
2021
| 08:18 Europe/Amsterdam
BIOTRONIK has announced a satellite symposium taking place at this week’s European Heart Rhythm Association’s (EHRA) online congress: ‘Less is more: Do we still need an atrial lead for atrial sensing?’. Expert physicians will discuss key outcomes fro...
Read more
06
April
2021
| 12:31 Europe/Amsterdam
Congestive Heart Failure is a common, costly, and potentially fatal condition affecting more than 64 million people globally. It is also the leading cause of both hospitalization and readmission amongst older adults. For some patients, a pacemaker ca...
Read more
18
March
2021
| 09:32 Europe/Amsterdam
Due to the high rates of mortality and morbidity in heart failure patients, it is essential that heart failure cases are continuously and proactively monitored. ...
Read more
15
March
2021
| 14:42 Europe/Amsterdam
BIOTRONIK’s ultrathin-strut stent, Orsiro®*, demonstrated superiority over Xience DES for target lesion failure (TLF) at 24 months, according to new follow-up data from the BIOSTEMI trial.1The latest results were presented by Prof. Thomas Pilgrim, In...
Read more
08
March
2021
| 10:30 Europe/Amsterdam
As we mark International Women’s Day in 2021, we’ve been reflecting on the invaluable contributions women make to science, technology, and clinical research. Women have long been at the forefront of scientific advances and this past year was no excep...
Read more
23
February
2021
| 09:10 Europe/Amsterdam
One thing our ongoing global pandemic hasn’t put on hold is the need to act early when providing emergency cardiovascular care. Heart attacks and strokes are still happening, even as it feels the world around us has slowed down. Heart researchers hav...
Read more
10
February
2021
| 16:18 Europe/Amsterdam
Despite being half the world’s population, women make up less than ten percent of students enrolled in subjects like statistics, mathematics, and engineering. At the same time, only about 30 percent of the world’s researchers are women. Recent UNESCO...
Read more
01
February
2021
| 10:45 Europe/Amsterdam
Recent data from the investigator-initiated, randomized controlled trial (RCT), BIOLUX AV, showed that the treatment of patients with dysfunctional hemodialysis access (HA), with BIOTRONIK’s Passeo®-18 LuxTM drug-coated balloon (DCB)*, is safe and ef...
Read more
28
January
2021
| 19:14 Europe/Amsterdam
The most recent series of Apple iPhones include a stronger magnetic array than previous models. A recent study1 published in the HeartRhythm Journal reported that therapy was suspended when an iPhone 12 was brought into close contact with specific im...
Read more
18
January
2021
| 08:29 Europe/Amsterdam
Implantable cardiac monitors allow for continuous long-term monitoring of a patient's heart rhythm and remotely transmit detected arrhythmias to the physician. In this interview, Helge Wuttig explains the advantages of this therapeutic method for the...
Read more
2020
09
December
2020
| 10:34 Europe/Amsterdam
Electrophysiologists in Europe will now have access to state-of-the-art, gold-tipped force sensing ablation catheters following the BIOTRONIK announcement today that AlCath Force is CE-market approved. With the release of the unique catheter, a full ...
Read more
02
December
2020
| 20:51 Europe/Amsterdam
As the global medical community continues the hard work of delivering patient care in the middle of an unprecedented pandemic, it is especially important for us as physicians to pay attention to where we might be able to streamline workloads - both f...
Read more
15
November
2020
| 17:56 Europe/Amsterdam
In their short time on the market, bioresorbable vascular scaffolds have generated plenty of discussion within interventional cardiology. According to the authors of “Fading Away or Hope for the Future,” published by the American College of Cardiolog...
Read more
29
October
2020
| 18:07 Europe/Amsterdam
About one in four people globally will have a stroke in their lifetimes. Stroke is the fifth-leading cause of death in the US and accounts for over a million deaths in Europe every year. The most common heart rhythm disorder—atrial fibrillation (AF)—...
Read more
01
October
2020
| 12:49 Europe/Amsterdam
 As we get older, our risk for a variety of cardiovascular conditions increases. It’s a fact that likely doesn’t come as a big surprise to many people—but that doesn’t mean the discussions aging patients need to have with their families and doctors g...
Read more
29
September
2020
| 08:26 Europe/Amsterdam
Walking about eight kilometres over the course of a week, at an average pace (3 km per hour), cuts the risk of cardiovascular events by almost a third. ...
Read more
17
September
2020
| 08:57 Europe/Amsterdam
Outcomes of the BIO4AMB trial presented at the CIRSE 2020 Summit demonstrated that ambulatory treatment with 4­‑French (4F) devices is a valid and safe option for endovascular treatment of lower extremity peripheral artery disease (PAD). The 4F compa...
Read more
07
September
2020
| 08:45 Europe/Amsterdam
BIOTRONIK today announced European market release of the Passeo®‑35 Xeo PTA (percutaneous transluminal angioplasty) balloon catheter. Compared to other available PTA balloons1, the device offers physicians improved crossability, excellent trackabilit...
Read more
01
September
2020
| 16:12 Europe/Amsterdam
A new study1 presented at this year’s European Society of Cardiology (ESC) Congress today shows that BIOTRONIK’s exclusive Closed Loop Stimulation (CLS) helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. ...
Read more